Home > Healthcare > Biotechnology > Biopharma > Microbiome Diagnostics Market

Microbiome Diagnostics Market Share

Report ID: GMI9140
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Microbiome Diagnostics Market Share

The microbiome diagnostics industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products and services based on different technologies is among a key market strategy. Some of the leading industry players have a notable presence in the market.

Microbiome Diagnostics Market Companies

Some of the eminent market participants operating in the microbiome diagnostics industry include:

Becton, Dickinson, and Company
Biome Technologies plc
Genetic Analysis AS
Illumina, Inc.
Microba Life Sciences Limited
Micronoma, Inc.
OraSure Technologies, Inc.
Oxford Nanopore Technologies plc
Quantbiome, Inc.
ViennaLab Diagnostics GmbH

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Microbiome diagnostics market size was USD 143.1 million in 2023 and is expected to register 13.4% CAGR from 2024-2032 owing to the increasing prevalence of chronic disease diseases including cardiovascular diseases, diabetes, and cancer worldwide.

The kits and reagents segment is expected to reach USD 296.6 million by 2032 due to providing standardized protocols and formulations ensuring consistency and reproducibility in microbiome sample preparation.

The U.S. microbiome diagnostics industry is expected to register 13.1% CAGR from 2024-2032 due to presence of world-renowned research institutions, academic centers, and biotechnology companies at the forefront of microbiome research in the country.

Genetic Analysis AS, Illumina, Inc., Microba Life Sciences Limited, Micronoma, Inc., OraSure Technologies, Inc., Oxford Nanopore Technologies plc, Quantbiome, Inc., and ViennaLab Diagnostics GmbH, are some of the major microbiome diagnostics companies worldwide.